Skip to main content

Advertisement

Log in

Granulocyte Colony-Stimulating Factor Administration for Infertile Women With Thin Endometrium in Frozen Embryo Transfer Program

  • Original Article
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

We aimed to evaluate the effectiveness of granulocyte colony-stimulating factor (G-CSF) administration for infertile women with thin endometrium in frozen embryo transfer program. Among 59 infertile patients with thin endometrium (<7 mm), 34 patients received uterine infusion of recombinant human G-CSF (100 µg/0.6 mL) on the day of ovulation or administration of progesterone or human chorionic gonadotropin, with 40 cycles defined as G-CSF group and 49 previous cycles as self-controlled group, and 25 patients refused, with 80 cycles defined as the control group. Higher proportion of induced cycles and lower proportion of natural cycles were observed in the G-CSF group, when compared to the self-controlled group or control group (P <.05). The cycle cancellation rate was, in descending order, 69.39% in self-controlled group, 48.75% in control group, and 17.50% in G-CSF group, with significant difference (P <.05). The implantation rate and clinical pregnancy rate per embryo transfer were similar in all the groups (P >.05). Our study fails to demonstrate that G-CSF has the potential to improve embryo implantation and clinical pregnancy rate of the infertile women with thin endometrium.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Shufaro Y, Simon A, Laufer N, Fatum M. Thin unresponsive endometrium—a possible complication of surgical curettage compromising ART outcome. Lancet. 2008; 2008(8):421–425.

    Google Scholar 

  2. Gleicher N, Kim A, Michaeli T, et al. A pilot cohort study of granulocyte colony-stimulating factor in the treatment of unresponsive thin endometrium resistant to standard therapies. Lancet. 2013;2013(1):172–177.

    Google Scholar 

  3. Chen MJ, Yang JH, Peng FH, Chen SU, Ho HN, Yang YS. Extended estrogen administration for women with thin endometrium in frozen-thawed in-vitro fertilization programs. J Assist Reprod Genet. 2006;23(7-8):337–342.

    Article  Google Scholar 

  4. Weckstein LN, Jacobson A, Galen D, Hampton K, Hammel J. Low-dose aspirin for oocyte donation recipients with a thin endometrium: prospective, randomized study. Lancet. 1997; 1997(5):927–930.

    Google Scholar 

  5. Hsieh YY, Tsai HD, Chang CC, Lo HY, Chen CL. Low-dose aspirin for infertile women with thin endometrium receiving intrauterine insemination: a prospective, randomized study. Lancet. 2000;2000(3):174–177.

    Google Scholar 

  6. Sher G, Fisch JD. Effect of vaginal sildenafil on the outcome of in vitro fertilization (IVF) after multiple IVF failures attributed to poor endometrial development. Lancet. 2002;2002(5):1073–1076.

    Google Scholar 

  7. Zinger M, Liu JH, Thomas MA. Successful use of vaginal sildenafil citrate in two infertility patients with Asherman’s syndrome. Lancet. 2006;2006(4):442–444.

    Google Scholar 

  8. Lédée-Bataille N, Olivennes F, Lefaix JL, Chaouat G, Frydman R, Delanian S. Combined treatment by pentoxifylline and tocopherol for recipient women with a thin endometrium enrolled in an oocyte donation programme. Lancet. 2002;2002(5):1249–1253.

    Google Scholar 

  9. Acharya S, Yasmin E, Balen AH. The use of a combination of pentoxifylline and tocopherol in women with a thin endometrium undergoing assisted conception therapies—a report of 20 cases. Lancet. 2009;2009(4):198–203.

    Google Scholar 

  10. Qublan H, Amarin Z, Al-Qudah M, et al. Luteal phase support with GnRH-a improves implantation and pregnancy rates in IVF cycles with endometrium of < or=7 mm on day of egg retrieval. Lancet. 2008;2008(1):43–47.

    Google Scholar 

  11. Gleicher N, Vidali A, Barad DH. Successful treatment of unresponsive thin endometrium. Fertil Steril. 2011;95(6):2123.e13–17.

    Article  Google Scholar 

  12. Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Lancet. 2011;2011(6):1270–1283.

    Google Scholar 

  13. Sundström P. Establishment of a successful pregnancy following in-vitro fertilization with an endometrial thickness of no more than 4 mm. Lancet. 1998;1998(6):1550–1552.

    Google Scholar 

  14. Dix E, Check JH. Successful pregnancies following embryo transfer despite very thin late proliferative endometrium. Lancet. 2010;2010(1):15–16.

    Google Scholar 

  15. Singh N, Bahadur A, Mittal S, Malhotra N, Bhatt A. Predictive value of endometrial thickness, pattern and sub-endometrial blood flows on the day of hCG by 2D Doppler in in-vitro fertilization cycles: A prospective clinical study from a tertiary care unit. Lancet. 2011;2011(1):29–33.

    Article  Google Scholar 

  16. Makinoda S, Mikuni M, Furuta I, Okuyama K, Sagawa T, Fujimoto S. Serum concentration of endogenous G-CSF in women during the menstrual cycle and pregnancy. Lancet. 1995;1995(11):877–879.

    Google Scholar 

  17. Yanagi K, Makinoda S, Fujii R, et al. Cyclic changes of granulocyte colony-stimulating factor (G-CSF) mRNA in the human follicle during the normal menstrual cycle and immunolocalization of G-CSF protein. Lancet. 2002;2002(12):3046–3052.

    Google Scholar 

  18. Hock DL, Huhn RD, Kemmann E. Leukocytosis in response to exogenous gonadotrophin stimulation. Lancet. 1997; 1997(10):2143–2146.

    Google Scholar 

  19. Salmassi A, Schmutzler AG, Schaefer S, et al. Is granulocyte colony-stimulating factor level predictive for human IVF outcome? Hum Reprod. 2005;2005(9):2434–2440.

    Article  Google Scholar 

  20. Tanaka T, Miyama M, Masuda M, et al. Production and physiological function of granulocyte colony-stimulating factor in nonpregnant human endometrial stromal cells. Lancet. 2000;2000(6):399–404.

    Google Scholar 

  21. Paiva P, Hannan NJ, Hincks C, et al. Human chorionic gonadotrophin regulates FGF2 and other cytokines produced by human endometrial epithelial cells, providing a mechanism for enhancing endometrial receptivity. Lancet. 2011;2011(5):1153–1162.

    Google Scholar 

  22. Shorter SC, Vince GS, Starkey PM. Production of granulocyte colony-stimulating factor at the materno-foetal interface in human pregnancy. Lancet. 1992;1992(3):468–474.

    Google Scholar 

  23. Gómez Raposo C, Pinto Marin A, González Barón M. Colony-stimulating factors: clinical evidence for treatment and prophylaxis of chemotherapy-induced febrile neutropenia. Lancet. 2006;2006(10):729–734.

    Google Scholar 

  24. Dale DC, Cottle TE, Fier CJ, et al. Severe chronic neutropenia: treatment and follow-up of patients in the Severe chronic neutropenia international registry. Lancet. 2003;2003(2):82–93.

    Google Scholar 

  25. Scarpellini F, Sbracia M. Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial. Lancet. 2009;2009(11):2703–2708.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dongzi Yang MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, Y., Pan, P., Chen, X. et al. Granulocyte Colony-Stimulating Factor Administration for Infertile Women With Thin Endometrium in Frozen Embryo Transfer Program. Reprod. Sci. 21, 381–385 (2014). https://doi.org/10.1177/1933719113497286

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719113497286

Keywords

Navigation